|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/166 | |
| A61K 9/00 | |||
| A61K 47/12 | |||
| A61K 47/18 | |||
| A61P 1/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 2747561 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12825447.1 |
| Date of filing the European patent application | 2012-08-23 | |
| (97) | Date of publication of the European application | 2014-07-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/052096 |
| Date | 2012-08-23 |
| (87) | Number | WO 2013/028882 |
| Date | 2013-02-28 |
| (30) | Number | Date | Country code |
| 201161527563 P | 2011-08-25 | US | |
| 201261583447 P | 2012-01-05 | US |
| (72) |
D`ONOFRIO, Matthew, J., US
GONYER, David, A., US
CARLSON, Marilyn, R., US
|
| (73) |
Evoke Pharma, Inc.,
420 Stevens Avenue, Suite 370, Solana Beach, CA 92075,
US
|
| (54) | TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS |
| TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS |